Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas

Neurosurgery

Volumn 59, Issue 4, 2006, Pages 902-909

  Ogden, Alfred T ^a   Horgan, David ^a   Waziri, Allen ^a   Anderson, David ^b   Louca, Joseph ^a   McKhann, Guy M ^a   Sisti, Michael B ^a   Parsa, Andrew T ^c   Bruce, Jeffrey N ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Defective monocytes; Dendritic cells; Flow cytometry; Glioblastoma monocytes; Glioma

Indexed keywords

CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HLA ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR VACCINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BRAIN METASTASIS; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD86; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELLS, CULTURED; COHORT STUDIES; DENDRITIC CELLS; FEMALE; GLIOBLASTOMA; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 33750088421     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000233907.03070.7B     Document Type: Article

References (36)

1. Akasaki Y, Kikuchi T, Homma S, Abe T, Kofe D, Ohno T: Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother 24:106-113, 2001.
2. Balkwill F, Osborne R, Burke F, Naylor S, Talbot D, Durbin H, Tavernier J, Fiers W: Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 2:1229-1232, 1987.
3. Cupps TR, Fauci AS: Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133-155, 1982.
4. De AK, Laudanski K, Miller-Graziano CL: Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J Immunol 170:6355-6362, 2003.
5. Dhabhar FS, Miller AH, McEwen BS, Spencer RL: Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol 157:1638-1644, 1996.
6. Dhodapkar MV, Steinman RM: Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100:174-177, 2002.
7. Dix AR, Brooks WH, Roszman TL, Morford LA: Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100:216-232, 1999.
8. Fries G, Perneczky A, Kempski O: Enhanced interleukin-1 beta release and longevity of glioma-associated peripheral blood monocytes in vitro. Neurosurgery 35:264-270, 1994.
9. Fries G, Perneczky A, Kempski O: Glioblastoma-associated circulating monocytes and the release of epidermal growth factor. J Neurosurg 85:642-647, 1996.
10. Gilhus NE: Effect of phenytoin and carbamazepine on subpopulations of mononuclear blood cells as defined by membrane antigens. Int Arch Allergy Appl Immunol 74:80-83, 1984.
11. Gilhus NE, Matre R, Aarli JA: Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. Int J Immunopharmacol 4:43-48, 1982.
12. Graf MR, Sauer JT, Merchant RE: Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas. J Neurooncol 73:29-36, 2005.
13. Harris JE, DeBoer KP, Vahey AL, Braun DP: The measurement of leukocyte subsets in the peripheral blood of cancer patients with solid tumors using monoclonal antibody reagents. Med Pediatr Oncol 10:185-194, 1982.
14. Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, Dranoff G, Bigner DD, Sampson JH: Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol 103:16-25, 2000.
15. Jontell M, Gabel H, Ohman SC, Brynger H: Class II antigen expression of epidermal Langerhans cells in renal allograft recipients. Transpl Int 1:186-189, 1988.
16. Kikuchi T, Abe T, Ohno T: Effects of glioma cells on maturation of dendritic cells. J Neurooncol 58:125-130, 2002.
17. Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T: Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50:337-344, 2001.
18. Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, Schuler G, Steinkasserer A: The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 194:1813-1821, 2001.
19. Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R: High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol 58:91-97, 2001.
20. Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM: Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 90:1115-1124, 1999.
21. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13:265-270, 1992.
22. Marcoli M, Gatti G, Ippoliti G, Lombardi M, Crema A, Zocchi MT, De Ponti F, Lecchini S, Frigo GM: Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients. Hum Toxicol 4:147-157, 1985.
23. Morford LA, Dix AR, Brooks WH, Roszman TL: Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors. J Neurosurg 91:935-946, 1999.
24. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL: T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 159:4415-4425, 1997.
25. Ni HT, Spellman SR, Jean WC, Hall WA, Low WC: Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neurooncol 51:1-9, 2001.
26. Scholler N, Hayden-Ledbetter M, Dahlin A, Hellstrom I, Hellstrom KE, Ledbetter JA: Cutting edge: CD83 regulates the development of cellular immunity. J Immunol 168:2599-2602, 2002.
27. Schreiber AD, Parsons J, McDermott P, Cooper RA: Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest 56:1189-1197, 1975.
28. Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V: Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 53:64-72, 2004.
29. Wilkinson JR, Lane SJ, Lee TH: Effects of corticosteroids on cytokine generation and expression of activation antigens by monocytes in bronchial asthma. Int Arch Allergy Appl Immunol 94:220-221, 1991.
30. Woiciechowsky C, Asadullah K, Nestler D, Schoning B, Glockner F, Docke WD, Volk HD: Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: Effect of tumor extirpation. J Neuroimmunol 84:164-171, 1998.
31. Wood GW, Morantz RA: Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cells. J Neurooncol 1:87-94, 1983.
32. Wood GW, Neff JE, Stephens R: Relationship between monocytosis and T-lymphocyte function in human cancer. J Natl Cancer Inst 63:587-592, 1979.
33. Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ: Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64:4973-4979, 2004.
34. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61:842-847, 2001.
35. Zhou LJ, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A 93:2588-2592, 1996.
36. Zou JP, Morford LA, Chougnet C, Dix AR, Brooks AG, Torres N, Shuman JD, Coligan JE, Brooks WH, Roszman TL, Shearer GM: Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J Immunol 162:4882-4892, 1999.